Protease Inhibitors Market worth USD XX Mn in 2019
Published | 26 November 2020
According to BlueWeave Consulting, the global
protease inhibitors market has reached USD XX Million in 2019 and is further
projected to reach USD XX Million by 2026, growing at a CAGR of XX% during the forecast
period. The increasing prevalence of viral diseases such as HIV/AIDS
and hepatitis C is expected to drive the market during the forecast period. The
rising awareness about anti-retroviral therapy and cancer treatment is another
major factor contributing to the growth of the global protease inhibitors
market. Extensive research and development activities in the field of protein
purification, pharmacology, animal tissue culture, and molecular biology are
expected to drive the global market by 2026.
Rising awareness about anti-retroviral therapy and cancer treatment
The global protease inhibitors market is expected to expand at a significant pace during the forecast period. The development of pharmaceutical protease inhibitors is of great interest which targets the specific protease enzyme (for example, in HIV anti-retroviral drugs). Thus, the increasing prevalence of viral diseases such as HIV/AIDS and hepatitis C is expected to drive the market during the forecast period. The rising awareness about anti-retroviral therapy and cancer treatment is another major factor contributing to the growth of the global protease inhibitors market. Extensive research and development activities in the field of protein purification, pharmacology, animal tissue culture, and molecular biology are expected to drive the global market by 2026.
Increasing cases of HIV infected people to boost market growth for protease inhibitor market
According to WHO, around 37.9 million people were living with HIV (including 1.7 million children), with a global HIV prevalence of 0.8% among adults in 2018 and this number is rising every year. With the rise in the number of infected people coupled with rising awareness among people about HIV, the demand for drugs for its treatment is also increasing which may boost the market growth. The increasing number of HIV cases globally coupled with the high prevalence of this disease along with the increasing number of tests for HIV diagnosis is expected to drive the market growth for the protease inhibitor market.
Time-consuming approval process of drugs to restrain the market growth
From the time of research and development to the official launch of drugs, it takes a very long time. Even after development and successful trials, approval from regulatory authority takes a lot of time and a lot of entrepreneurs and big players do not invest in drug manufacturing due to this reason. So, the launching of the drug takes a lot of time which is declining the protease inhibitor market growth. Over the forecast period, this may hamper the growth of injectable drugs for the type 2 diabetes market.
Serine protease inhibitors segment occupy the major share of the global protease inhibitors market
The serine protease inhibitor segment leads to the protease inhibitors market. It is anticipated to drive the growth for antiretroviral drugs in the protease inhibitors market on the back of its effectiveness in the treatment. Serine protease inhibitor forms a proteolytically inactive stoichiometric complex with the Serpins proteases which will play a vital role in the regulation of blood coagulation, complement activation, generation of kinins, and fibrinolysis. Thus, owing to its huge effectiveness in the therapy the protease inhibitors market will grow at a higher rate during the forecasting period.
Global protease inhibitors market: Regional insights
Factors such as the high prevalence of HIV and chronic HCV in the region, the growing industrial sector, and advanced health care infrastructure are anticipated to drive the market in North America during the forecast period. Furthermore, to strengthen their position in an established market, prominent players are focusing on the region. The market in the Asia Pacific is expected to register the maximum growth rate during the forecast period, due to factors such as rising health care expenditure, increasing geriatric population, surging disposable income, high prevalence of chronic diseases, growing focus of global pharmaceutical companies on the Asia Pacific, and increasing research activities. Furthermore, a rise in awareness about anti-retroviral therapy in regions are driving the global protease inhibitors market.
The leading players” in the global protease inhibitors market include Thermo Fisher Scientific Inc., Sigma-Aldrich, Inc., CYTOSKELETON, INC., Merck & Co., Inc., Genentech, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Bristol-Myers Squibb Company, Janssen Pharmaceutical Companies, GlaxoSmithKline plc, Vertex Pharmaceuticals, CSL Behring LLC., Takeda Pharmaceutical Company Limited, Pharming Technologies B.V., KalVista Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Ionis Pharmaceuticals, Inc., Centogene AG & Other prominent players. key players in the protease inhibitors market are engaged in mergers and acquisitions, extensive R&D activities, the launch of cost-effective and efficient vaccine products, and collaborative partnerships.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of global Protease Inhibitors market size & forecast. The report promises to provide recent technology trends of Protease Inhibitors market and industry insights which help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides all kinds of Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions company providing agile assistance to make your business endeavors successful.
Recent Press Releases
- Global Cheese market was valued at US$ 8,359.4 Mn in 2016 and it is expected to reach at US$ 25,869 Mn by 2025
- Dairy Product Market is anticipated to worth USD 645.5 million by 2025
- Global Sepsis Diagnostics Market Witnessing Vigorous Growth: Projected to Grow at a CAGR of 10.5% in the Forecast Period
- Global Virtual Sensors Market will boost by increasing adoption internet of things applications and cloud platform
- Global PC Gaming Peripherals Market is achieving new heights on accounts of rising innovations and digitization in technologies such as Artificial intelligence (AI), Internet of things (IOT)
- Product Information Management (PIM) Market is Projected to Reach USD 17.9 Billion by 2027